<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NMRA
Neumora Therapeutics
$
()


  • Fly Intel: Pre-market Movers

    4/15/2024 - 08:53am
  • Neumora Therapeutics falls 23% after FDA clinical hold of Phase 1 NMRA-266 study

    4/15/2024 - 06:47am
  • Neumora Therapeutics announces clinical hold of Phase 1 NMRA-266 study

    4/15/2024 - 06:32am
  • Neumora weakness amid lock-up expiration a buying opportunity, says RBC Capital

    3/13/2024 - 12:46pm
  • Neumora Therapeutics price target raised by $7 at RBC Capital, here's why

    3/8/2024 - 08:57am
  • Neumora Therapeutics reports Q4 EPS (71c), consensus (55c)

    3/7/2024 - 07:01am
  • JPMorgan biotech analysts to hold an analyst/industry conference call

    2/23/2024 - 11:55am
  • JPMorgan biotech analysts to hold an analyst/industry conference call

    2/23/2024 - 11:00am
  • Neumora Therapeutics appoints Panandiker as Chief Commercial Officer

    1/22/2024 - 07:08am
  • The biopharmaceuticals stocks to own in 2024, according to BofA

    1/3/2024 - 10:47am
  • Neumora Therapeutics price target raised by $2 at BofA, here's why

    1/3/2024 - 07:10am
  • Neumora Therapeutics appoints Jason Duncan as CLO

    12/12/2023 - 07:09am
  • Neumora Therapeutics initiated with neutral view at Deutsche Bank, here's why

    12/11/2023 - 16:29pm
  • After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next

    12/7/2023 - 12:00pm
  • Neumora Therapeutics announces NMRA-266 IND clearance, initiation Phase 1 study

    11/27/2023 - 07:04am
dynamic_feed Breaking News